Pharmaceutical market: worldwide revenue 2001-2023

The global pharmaceutical market has experienced significant growth in recent years. For 2023, the total global pharmaceutical market was estimated at around 1.6 trillion U.S. dollars. This is an increase of over 100 billion dollars compared to 2022.Global pharmaceutical markets Globally, the United States is by far the leading market for pharmaceuticals, followed by other developed countries and emerging markets. Emerging markets can include middle and low-income countries such as Brazil, India, Russia, Colombia and Egypt, to name a few. Despite increasing revenues globally, the Latin American region accounts for the lowest share of the global pharmaceutical market’s revenues. Top pharmaceuticals globally The top pharmaceutical products sold globally include Humira, Eliquis and Revlimid. Oncology is the op therapeutic area for drug sales globally and it is expected to show the largest growth over the next years. It is followed by drug spending for autoimmune diseases and diabetes. During the height of the COVID-19 pandemic, covid vaccine Comirnaty was the world's top revenue generating pharmaceutical product.

近年来，全球医药市场经历了显著的增长。截至2023年，全球医药市场的总估计值约为16兆美元。与2022年相比，这一数字增长了超过1000亿美元。在全球范围内，美国无疑是医药市场的领先者，紧随其后的是其他发达国家及新兴市场。新兴市场可能包括巴西、印度、俄罗斯、哥伦比亚和埃及等中等收入和低收入国家。尽管全球收入不断增长，拉丁美洲地区在全球医药市场收入中所占份额仍然最低。在全球范围内，最畅销的医药产品包括Humira、Eliquis和Revlimid。肿瘤学是全球药物销售的领先治疗领域，预计在未来几年内将实现最大的增长。其后依次是自身免疫性疾病和糖尿病的药物支出。在COVID-19大流行的高峰期，Comirnaty新冠疫苗成为了全球收入最高的医药产品。